An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 133-139

  Chen, Changguo ^a   Johnston, Thomas D ^a   Jeon, Hoonbae ^a   Gedaly, Roberto ^a   McHugh, Patrick P ^a   Burke, Thomas G ^b   Ranjan, Dinesh ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

Curcumin; EBV transformed B cells; Human lymphocytes; Human splenocytes; Liposome

Indexed keywords

CHOLESTEROL; CURCUMIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; LIPID; LIPOSOME; PHOSPHATE BUFFERED SALINE;

ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG STABILITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TOXICITY TESTING;

ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; CURCUMIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG STABILITY; HERPESVIRUS 4, HUMAN; HUMANS; LIPOSOMES; LYMPHOCYTES; PHOSPHATIDYLGLYCEROLS; SPLEEN; TOXICITY TESTS;

EID: 57849106304     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.009     Document Type: Article

References (19)

1. Ammon H.P., Safayhi H., Mack T., and Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J. Ethnopharmacol. 38 (1993) 113-119
2. Anand P., Kunnumakkara A.B., Newman R.A., and Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharmcol. 4 (2007) 807-818
3. Berrocal M.C., Bujan J., Garcia-Honduvilla N., and Abeger A. Comparison of the effects of dimyristoyl and soya phosphatidylcholine liposomes on human fibroblasts. Drug Deliv. 7 (2000) 37-44
4. Campbell P.I. Toxicity of some charged lipids used in liposome preparations. Cytobios 37 (1983) 21-26
5. Chueh S.C., Lai M.K., Liu I.S., Teng F.C., and Chen J. Curcumin enhances the immunosuppressive activity of cyclosporine in rat cardiac allografts and in mixed lymphocyte reactions. Transplant. Proc. 35 (2003) 1603-1605
6. Fimognari C., Nusse M., Cesari R., Iori R., Cantelli-Forti G., and Hrelia P. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 23 (2002) 581-586
7. Kuhn S.H., Gemperli B., Shephard E.G., Joubert J.R., Weidemann P.A., Weissmann G., and Finkelstein M.C. Interaction of liposomes with human leukocytes in whole blood. Biochim. Biophys. Acta 762 (1983) 119-127
8. Li L., Ahmed B., Mehta K., and Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol. Cancer Ther. 6 (2007) 1276-1282
9. Li L., Braiteh F.S., and Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104 (2005) 1322-1331
10. Mayhew E., Ito M., and Lazo R. Toxicity of non-drug-containing liposomes for cultured human cells. Exp. Cell Res. 171 (1987) 195-202
11. Ranjan D., Chen C., Johnston T.D., Jeon H., and Nagabhushan M. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J. Surg. Res. 121 (2004) 171-177
12. Ranjan D., Johnston T.D., Reddy K.S., Wu G., Bondada S., and Chen C. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin. J. Surg. Res. 87 (1999) 1-5
13. Ranjan D., Johnston T.D., Wu G., Elliott L., Bondada S., and Nagabhushan M. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J. Surg. Res. 77 (1998) 174-178
14. Ranjan D., Siquijor A., Johnston T.D., Wu G., and Nagabhuskahn M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. Am. Surg. 64 (1998) 47-51
15. Rao C.V., Rivenson A., Simi B., and Reddy B.S. Chemoprevention of colon cancer by dietary curcumin. Ann. N. Y. Acad. Sci. 768 (1995) 201-204
16. Sampedro F., Partika J., Santalo P., Molins-Pujol A.M., Bonal J., and Perez-Soler R. Liposomes as carriers of different new lipophilic antitumour drugs: a preliminary report. J. Microencapsul. 11 (1994) 309-318
17. Samuni A.M., and Barenholz Y. Use of nitroxides to protect liposomes against oxidative damage. Methods Enzymol. 387 (2004) 299-314
18. Smistad G., Jacobsen J., and Sande S.A. Multivariate toxicity screening of liposomal formulations on a human buccal cell line. Int. J. Pharm. 330 (2007) 14-22
19. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., and Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997) 1867-1876